Atlas Trials

A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]

Clinical trial NCT01714037 · TERMINATED

Trial details

NCT number
NCT01714037
Sponsor
Debiopharm International SA
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2012-08-01
Primary completion
2014-11-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.